CD79A and cancer: It is not clear whether the increase in IgA and B cells induced by L.RGG in our study represents a response to bacteria exposure or to cancer cells; however, we speculate that, even in the case of a response to bacteria, modulation of the surrounding tumor microenvironment could make it permissive for antitumor effects and result in priming an antitumor immune response.